BSX vs XAIR · P/E 20, rev $10.65B vs rev $7.7M
Boston Scientific Corp (BSX) versus Beyond Air Inc (XAIR) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Beyond Air Inc (XAIR) is a medical devices company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported XAIR revenue for 2026-03-31 was $7.7M. Net income was -$33.2M. Revenue was up 107.3% from 2025-03-31 to 2026-03-31. XAIR currently screens at market cap $16.0M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. XAIR currently screens at market cap $16.0M.
Not investment advice. Open the BSX and XAIR stock pages for the full models.
Not investment advice.